MYC and pulmonary arterial hypertension: The upstream regulator MYC was identified to link to many of the protein changes (p<0.05) identified in the comparison between the various treatment groups (PAH-PBS vs Healthy (left panel) and PAH-CDC vs PAH-PBS (right panel)).